Navigation Links
Jazz Pharmaceuticals Announces Participation In Upcoming Investor Events
Date:5/13/2013

DUBLIN, May 13, 2013 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will participate in three upcoming investor events. A live audio webcast of each presentation may be accessed from the Investors section of the Jazz Pharmaceuticals website at www.jazzpharmaceuticals.com. The events, presentation times and speakers include:

  • UBS Global Healthcare Conference in New York, NY on Tuesday, May 21, 2013 at 9:30 a.m. EDT/2:30 p.m. IST. Kathryn E. Falberg , executive vice president and chief financial officer, will provide a business update.
  • Jefferies 2013 Global Healthcare Conference in New York, NY on Tuesday, June 4, 2013 at 8:30 a.m. EDT/1:30 p.m. IST. Bruce C. Cozadd , chairman and chief executive officer, will provide a business update.
  • Lazard Capital Markets Conference Call at the 27th Annual Meeting of the American Academy of Sleep Medicine in Baltimore, MD on Wednesday, June 5, 2013 at 12:30 p.m. EDT/5:30 p.m. IST. Company management will discuss data being presented, including findings from the Burden of Narcolepsy Disease (BOND) study, and other business matters.

An archived version of each audio webcast will be available for at least one week following each respective presentation on the Investors section of the company's website at www.jazzpharmaceuticals.com.

About Jazz Pharmaceuticals

Jazz Pharmaceuticals plc is a specialty biopharmaceutical company focused on improving patients' lives by identifying, developing and commercializing innovative products that address unmet medical needs. The company has a diverse portfolio of products in the areas of narcolepsy, oncology, pain and psychiatry. The company's U.S. marketed products in these areas include: Xyrem® (sodium oxybate) oral solution, Erwinaze® (asparaginase Erwinia chrysanthemi), Prialt® (ziconotide) intrathecal infusion and FazaClo® (clozapine, USP) HD. Outside of the U.S., Jazz Pharmaceuticals also has a number of products marketed by its EUSA Pharma division. For further information, see www.jazzpharmaceuticals.com.


'/>"/>
SOURCE Jazz Pharmaceuticals plc
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Anthera Pharmaceuticals Reports 2013 First Quarter Financial Results
2. Arbor Pharmaceuticals Announces FDA Approval of First NDA
3. Optimer Pharmaceuticals Appoints Eric Sirota as Chief Operating Officer
4. Valeant Pharmaceuticals To Webcast 2013 Annual Meeting Of Shareholders
5. Isis Pharmaceuticals to Present at the 2013 UBS Global Healthcare Conference
6. Actinium Pharmaceuticals, Inc. Receives Notice of Patent Allowance for a Key Application
7. Valeant Pharmaceuticals International, Inc. Announces Additional Information Regarding Continuance Proposal
8. Auxilium Pharmaceuticals, Inc. To Present At The Bank Of America Merrill Lynch 2013 Health Care Conference
9. The Zacks Analyst Blog Highlights: Exxon Mobil, Statoil, Chevron, Braskem and Cubist Pharmaceuticals
10. Arena Pharmaceuticals to Present at the Bank of America Merrill Lynch 2013 Health Care Conference
11. Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2013 First Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... , Dec. 1, 2016  Today, Simpson Healthcare Executives, ... honor of being selected as winners of multiple awards ... Executives Website at the PLATINUM level, Blue Zones Menu ... at the GOLD Level, and our proprietary 3ConneX Platform ... Simpson Healthcare Executives, we are excited to showcase our ...
(Date:12/2/2016)... Allergan plc (NYSE: AGN ), a ... previously announced Accelerated Share Repurchase (ASR) Program. Logo - ... ... previously announced, the Company entered into a variable tenor ASR ... repurchase $10 billion of its ordinary shares. Approximately 40.5 million ...
(Date:11/30/2016)... 2016 Research and Markets has announced the ... MedCore" report to their offering. ... , Detachable coil embolization is ... malformations. The detachable coil embolization treatment of cerebral aneurysms is less invasive ... weakened area in the wall of an artery in the brain. This ...
Breaking Medicine Technology:
(Date:12/2/2016)... ... December 02, 2016 , ... Center for Autism and Related Disorders (CARD) ... by autism spectrum disorder (ASD) and other developmental disabilities. The group, which is being ... and other caregivers the opportunity to share stories and advice, seek help, and continue ...
(Date:12/2/2016)... ... 02, 2016 , ... Dr. Raffi Hovsepian, a leading plastic, ... 2016 “Guide to America’s Top Plastic Surgeons” for seven consecutive years. The prestigious ... experience, and professional associations. , One the most frequently honored surgeons in ...
(Date:12/2/2016)... ... December 02, 2016 , ... Universal Medical ... systems and the first company to offer robotic imaging to veterinary medicine is ... booth # 941 for the American Association of Equine Practitioners 62nd Annual Convention ...
(Date:12/2/2016)... San Francisco, CA (PRWEB) , ... December 02, ... ... in digitally-enabled care journeys, announced today that it has raised $6.0 million in ... are inspired by Clarify Health’s conviction that patients and their caregivers can receive ...
(Date:11/30/2016)... Massachusetts (PRWEB) , ... November 30, 2016 , ... ... proud to announce that we have been designated as a Cigna Infertility Center ... or exceed rigorous performance standards. , “It’s an honor to be designated ...
Breaking Medicine News(10 mins):